Update expected from Glaxo on swine flu drugs
One of the firms at the forefront of fighting the swine flu pandemic is today expected to give an update on its anti H1N1 drugs.
GlaxoSmithKline is one of several companies charged with producing a vaccine for H1N1 after the World Health Organisation (WHO) declared it a pandemic last month.
CONNECT WITH US TODAY
Be the first to know the latest news and updates